Gracell Biotechnologies
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $624,658,000.
Profit Margin
| 2018 | 0 | -60.79M | |
|---|---|---|---|
| 2019 | 0 | -132.17M | |
| 2020 | 0 | -197.16M | |
| 2021 | 366K | -465.88M | -127289.62% |
| 2022 | 0 | -607.50M |
GRCL Income Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 366K | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 366K | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 485.38M | 326.89M | 168.83M | 119.21M | 52.24M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 624.65M | 463.93M | 214.39M | 146.58M | 62.50M |
Operating income | -624.65M | -463.57M | -214.39M | -146.58M | -62.50M |
Other income (expenses), net | 17.17M | 11.81M | 2.49M | 7.91M | 276K |
Income before tax | -607.48M | -451.75M | -211.9M | -138.66M | -60.79M |
Income tax expense | 22K | 14.12M | -14.73M | -6.48M | 1.71M |
Net income | -607.50M | -465.88M | -197.16M | -132.17M | -60.79M |
Earnings per share | |||||
Basic EPS | -5.65 | -7.08 | -3.01 | -6.67 | -3.07 |
Diluted EPS | -5.65 | -7.08 | -3.01 | -6.67 | -3.07 |
| Data source | Data source | Data source |